Technical Analysis for MYMX - Mymetics Corp

Grade Last Price % Change Price Change
grade B 0.0359 -16.32% -0.0070
MYMX closed down 16.32 percent on Friday, August 23, 2019, on 18 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical MYMX trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
MACD Bearish Centerline Cross Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish -16.32%
Crossed Above 50 DMA Bullish -16.32%
MACD Bullish Centerline Cross Bullish -16.32%
180 Bullish Setup Bullish Swing Setup -16.32%
Bollinger Band Squeeze Range Contraction -16.32%

Older signals for MYMX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Mymetics Corporation is a vaccine company. The Company is focused on developing vaccines for infectious diseases. The Company has over five vaccine candidates in its pipeline: human immunodeficiency virus type 1 (HIV-1)/acquired immune deficiency syndrome (AIDS), intra nasal Influenza, Malaria, Herpes Simplex Virus (HSV) and the Respiratory Syncitial Virus (RSV) vaccine. Its technology utilizes virosomes, lipid-based carriers containing functional fusion viral proteins and natural membrane proteins, in combination with rationally designed antigens. Its prophylactic HIV-1 vaccine candidate is constituted of virosomes linked to conserved antigens derived from the HIV-1 glycoprotein 41 (gp41) proteins from the clade B. The RSV vaccine consists of the reconstituted membrane of RSV containing the native viral proteins. The HSV vaccine candidate consists of the reconstituted membrane of HSV-1 or HSV-2. The intranasal influenza vaccine includes the reconstituted membrane of influenza virus.
Medicine RTT Medical Specialties Branches Of Biology Infectious Diseases Influenza Vaccines Vaccination Malaria Sexually Transmitted Diseases And Infections Hiv/Aids Aids Immune Deficiency Syndrome Influenza Virus
Is MYMX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 0.077
52 Week Low 0.02
Average Volume 52,846
200-Day Moving Average 0.0439
50-Day Moving Average 0.0398
20-Day Moving Average 0.0419
10-Day Moving Average 0.0409
Average True Range 0.006
ADX 33.18
+DI 15.9953
-DI 30.3318
Chandelier Exit (Long, 3 ATRs ) 0.0334
Chandelier Exit (Short, 3 ATRs ) 0.0485
Upper Bollinger Band 0.0485
Lower Bollinger Band 0.0353
Percent B (%b) 0.05
BandWidth 31.50358
MACD Line -0.0003
MACD Signal Line 0.0003
MACD Histogram -0.0006
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0493
Resistance 3 (R3) 0.0507 0.0478 0.0470
Resistance 2 (R2) 0.0478 0.0444 0.0470 0.0463
Resistance 1 (R1) 0.0418 0.0423 0.0404 0.0404 0.0455
Pivot Point 0.0389 0.0389 0.0381 0.0381 0.0389
Support 1 (S1) 0.0329 0.0355 0.0315 0.0315 0.0263
Support 2 (S2) 0.0300 0.0334 0.0292 0.0255
Support 3 (S3) 0.0240 0.0300 0.0248
Support 4 (S4) 0.0226